Corticotropin releasing factor antagonists
 Corticotropin-releasing factor (CRF) antagonists having formulae (I), (II) or (III) wherein the dashed lines, A, B, Y, Z, G, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.16 and R.sub.17 are as defined in the description, and processes for preparing them. These compounds and their pharmaceutically acceptable salts are useful in the treatment of CNS and stress-related disorders. ##STR1## 
Pfizer Inc.
A A C A A C A C C A A C A A A A A A C A A A A A C A C C A C A A A C A A A A A
A61P A61P C07D A61P A61P C07D A61P C07D C07D A61P A61P C07D A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D A61P C07D C07D A61P C07D A61P A61P A61P C07D A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yuhpyng Liang
Chen